Zinc in PDB 5b25: Crystal Structure of Human PDE1B with Inhibitor 3
Enzymatic activity of Crystal Structure of Human PDE1B with Inhibitor 3
All present enzymatic activity of Crystal Structure of Human PDE1B with Inhibitor 3:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human PDE1B with Inhibitor 3, PDB code: 5b25
was solved by
K.Ida,
W.Lane,
G.Snell,
S.Sogabe,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
40.00 /
1.90
|
Space group
|
P 43 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
102.875,
102.875,
294.848,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.2 /
20.3
|
Other elements in 5b25:
The structure of Crystal Structure of Human PDE1B with Inhibitor 3 also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human PDE1B with Inhibitor 3
(pdb code 5b25). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human PDE1B with Inhibitor 3, PDB code: 5b25:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5b25
Go back to
Zinc Binding Sites List in 5b25
Zinc binding site 1 out
of 4 in the Crystal Structure of Human PDE1B with Inhibitor 3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human PDE1B with Inhibitor 3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn601
b:31.2
occ:1.00
|
OD2
|
A:ASP264
|
2.0
|
19.9
|
1.0
|
OD1
|
A:ASP370
|
2.1
|
17.9
|
1.0
|
NE2
|
A:HIS227
|
2.2
|
18.6
|
1.0
|
NE2
|
A:HIS263
|
2.3
|
17.1
|
1.0
|
O
|
A:HOH739
|
2.3
|
18.1
|
1.0
|
O
|
A:HOH733
|
2.3
|
15.8
|
1.0
|
CG
|
A:ASP370
|
3.1
|
19.9
|
1.0
|
CD2
|
A:HIS263
|
3.1
|
14.7
|
1.0
|
CG
|
A:ASP264
|
3.1
|
19.3
|
1.0
|
CE1
|
A:HIS227
|
3.2
|
17.5
|
1.0
|
CD2
|
A:HIS227
|
3.2
|
18.8
|
1.0
|
OD2
|
A:ASP370
|
3.3
|
23.3
|
1.0
|
CE1
|
A:HIS263
|
3.4
|
19.0
|
1.0
|
OD1
|
A:ASP264
|
3.7
|
17.9
|
1.0
|
MG
|
A:MG602
|
4.0
|
26.1
|
1.0
|
O
|
A:HOH865
|
4.1
|
17.8
|
1.0
|
CD2
|
A:HIS223
|
4.1
|
15.8
|
1.0
|
O
|
A:HOH734
|
4.2
|
15.4
|
1.0
|
NE2
|
A:HIS223
|
4.2
|
16.8
|
1.0
|
CB
|
A:ASP264
|
4.3
|
16.3
|
1.0
|
CG
|
A:HIS263
|
4.3
|
17.3
|
1.0
|
ND1
|
A:HIS227
|
4.3
|
18.3
|
1.0
|
CG
|
A:HIS227
|
4.4
|
17.9
|
1.0
|
ND1
|
A:HIS263
|
4.4
|
17.4
|
1.0
|
CB
|
A:ASP370
|
4.4
|
16.4
|
1.0
|
O
|
A:HOH713
|
4.8
|
16.6
|
1.0
|
CG2
|
A:VAL231
|
4.8
|
15.0
|
1.0
|
CA
|
A:ASP370
|
4.9
|
16.5
|
1.0
|
O
|
A:ASP370
|
4.9
|
18.6
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5b25
Go back to
Zinc Binding Sites List in 5b25
Zinc binding site 2 out
of 4 in the Crystal Structure of Human PDE1B with Inhibitor 3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human PDE1B with Inhibitor 3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn601
b:29.3
occ:1.00
|
OD2
|
B:ASP264
|
2.0
|
15.9
|
1.0
|
OD1
|
B:ASP370
|
2.2
|
18.3
|
1.0
|
NE2
|
B:HIS227
|
2.2
|
15.1
|
1.0
|
O
|
B:HOH760
|
2.2
|
16.5
|
1.0
|
O
|
B:HOH702
|
2.3
|
15.7
|
1.0
|
NE2
|
B:HIS263
|
2.3
|
14.8
|
1.0
|
CG
|
B:ASP370
|
3.1
|
19.4
|
1.0
|
CD2
|
B:HIS263
|
3.1
|
13.6
|
1.0
|
CG
|
B:ASP264
|
3.1
|
18.2
|
1.0
|
CD2
|
B:HIS227
|
3.1
|
15.9
|
1.0
|
CE1
|
B:HIS227
|
3.2
|
16.0
|
1.0
|
OD2
|
B:ASP370
|
3.3
|
23.2
|
1.0
|
CE1
|
B:HIS263
|
3.4
|
13.6
|
1.0
|
OD1
|
B:ASP264
|
3.7
|
18.3
|
1.0
|
MG
|
B:MG602
|
4.0
|
26.9
|
1.0
|
O
|
B:HOH862
|
4.1
|
17.8
|
1.0
|
O
|
B:HOH723
|
4.1
|
14.6
|
1.0
|
CD2
|
B:HIS223
|
4.2
|
15.2
|
1.0
|
CB
|
B:ASP264
|
4.3
|
15.0
|
1.0
|
CG
|
B:HIS263
|
4.3
|
15.2
|
1.0
|
CG
|
B:HIS227
|
4.3
|
15.6
|
1.0
|
ND1
|
B:HIS227
|
4.3
|
17.1
|
1.0
|
NE2
|
B:HIS223
|
4.4
|
15.6
|
1.0
|
ND1
|
B:HIS263
|
4.4
|
13.2
|
1.0
|
CB
|
B:ASP370
|
4.4
|
15.5
|
1.0
|
O
|
B:HOH714
|
4.7
|
17.8
|
1.0
|
CG2
|
B:VAL231
|
4.8
|
14.6
|
1.0
|
O
|
B:ASP370
|
4.9
|
18.3
|
1.0
|
CA
|
B:ASP370
|
4.9
|
15.7
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5b25
Go back to
Zinc Binding Sites List in 5b25
Zinc binding site 3 out
of 4 in the Crystal Structure of Human PDE1B with Inhibitor 3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human PDE1B with Inhibitor 3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn601
b:29.8
occ:1.00
|
OD2
|
C:ASP264
|
2.1
|
16.4
|
1.0
|
OD1
|
C:ASP370
|
2.1
|
17.4
|
1.0
|
NE2
|
C:HIS227
|
2.2
|
16.2
|
1.0
|
O
|
C:HOH701
|
2.3
|
13.8
|
1.0
|
NE2
|
C:HIS263
|
2.3
|
15.9
|
1.0
|
O
|
C:HOH765
|
2.3
|
18.1
|
1.0
|
CG
|
C:ASP370
|
3.0
|
19.0
|
1.0
|
CD2
|
C:HIS263
|
3.1
|
14.1
|
1.0
|
CD2
|
C:HIS227
|
3.1
|
16.4
|
1.0
|
CG
|
C:ASP264
|
3.2
|
16.0
|
1.0
|
CE1
|
C:HIS227
|
3.3
|
17.3
|
1.0
|
OD2
|
C:ASP370
|
3.3
|
20.3
|
1.0
|
CE1
|
C:HIS263
|
3.4
|
14.9
|
1.0
|
OD1
|
C:ASP264
|
3.7
|
14.6
|
1.0
|
MG
|
C:MG602
|
3.9
|
26.5
|
1.0
|
O
|
C:HOH875
|
4.1
|
17.6
|
1.0
|
CD2
|
C:HIS223
|
4.2
|
13.0
|
1.0
|
O
|
C:HOH729
|
4.2
|
14.3
|
1.0
|
CG
|
C:HIS263
|
4.3
|
15.4
|
1.0
|
CB
|
C:ASP264
|
4.3
|
14.5
|
1.0
|
CG
|
C:HIS227
|
4.3
|
16.6
|
1.0
|
NE2
|
C:HIS223
|
4.3
|
15.7
|
1.0
|
ND1
|
C:HIS227
|
4.3
|
15.5
|
1.0
|
ND1
|
C:HIS263
|
4.4
|
15.1
|
1.0
|
CB
|
C:ASP370
|
4.4
|
14.8
|
1.0
|
CG2
|
C:VAL231
|
4.7
|
12.9
|
1.0
|
O
|
C:HOH708
|
4.8
|
18.8
|
1.0
|
O
|
C:ASP370
|
4.8
|
16.0
|
1.0
|
CA
|
C:ASP370
|
4.9
|
14.9
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5b25
Go back to
Zinc Binding Sites List in 5b25
Zinc binding site 4 out
of 4 in the Crystal Structure of Human PDE1B with Inhibitor 3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human PDE1B with Inhibitor 3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn601
b:29.7
occ:1.00
|
OD2
|
D:ASP264
|
2.1
|
18.1
|
1.0
|
OD1
|
D:ASP370
|
2.1
|
15.9
|
1.0
|
NE2
|
D:HIS227
|
2.3
|
15.9
|
1.0
|
O
|
D:HOH703
|
2.3
|
14.3
|
1.0
|
O
|
D:HOH793
|
2.3
|
15.9
|
1.0
|
NE2
|
D:HIS263
|
2.3
|
14.7
|
1.0
|
CG
|
D:ASP370
|
3.0
|
15.5
|
1.0
|
CD2
|
D:HIS263
|
3.1
|
15.2
|
1.0
|
CG
|
D:ASP264
|
3.1
|
18.2
|
1.0
|
CD2
|
D:HIS227
|
3.2
|
17.5
|
1.0
|
CE1
|
D:HIS227
|
3.3
|
16.1
|
1.0
|
OD2
|
D:ASP370
|
3.3
|
19.7
|
1.0
|
CE1
|
D:HIS263
|
3.4
|
15.7
|
1.0
|
OD1
|
D:ASP264
|
3.7
|
17.5
|
1.0
|
MG
|
D:MG602
|
3.9
|
28.7
|
1.0
|
O
|
D:HOH863
|
4.0
|
17.6
|
1.0
|
O
|
D:HOH714
|
4.2
|
14.7
|
1.0
|
CD2
|
D:HIS223
|
4.2
|
16.0
|
1.0
|
CB
|
D:ASP264
|
4.2
|
16.2
|
1.0
|
CG
|
D:HIS263
|
4.3
|
16.8
|
1.0
|
NE2
|
D:HIS223
|
4.3
|
17.7
|
1.0
|
CG
|
D:HIS227
|
4.3
|
16.6
|
1.0
|
ND1
|
D:HIS227
|
4.4
|
16.8
|
1.0
|
CB
|
D:ASP370
|
4.4
|
14.5
|
1.0
|
ND1
|
D:HIS263
|
4.4
|
16.0
|
1.0
|
O
|
D:HOH732
|
4.8
|
16.6
|
1.0
|
CG2
|
D:VAL231
|
4.8
|
14.7
|
1.0
|
O
|
D:ASP370
|
4.9
|
16.6
|
1.0
|
CA
|
D:ASP370
|
4.9
|
13.8
|
1.0
|
|
Reference:
P.Li,
H.Zheng,
J.Zhao,
L.Zhang,
W.Yao,
H.Zhu,
J.D.Beard,
K.Ida,
W.Lane,
G.Snell,
S.Sogabe,
C.J.Heyser,
G.L.Snyder,
J.P.Hendrick,
K.E.Vanover,
R.E.Davis,
L.P.Wennogle.
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 For the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases J.Med.Chem. V. 59 1149 2016.
ISSN: ISSN 0022-2623
PubMed: 26789933
DOI: 10.1021/ACS.JMEDCHEM.5B01751
Page generated: Sun Oct 27 13:18:19 2024
|